The Results of Intensive Chemotherapy Protocols in Children with High Risk Acute Lymphoblastic Leukemia (CCG-106 B, CCG-1882-Augmented BFM and CCG-1961)

Yavuz G.; Unal E.; Tacyildiz N.; Dincaslan H.; Ikinciogullari A.; Dogu F.; Tanyildiz G.; Aksoy B.; Pekpak E.; Asarcikli F.; Babacan E.; Gozdasoglu S.; Cavdar A.

首页> 外文期刊>Pediatric blood & cancer >The Results of Intensive Chemotherapy Protocols in Children with High Risk Acute Lymphoblastic Leukemia (CCG-106 B, CCG-1882-Augmented BFM and CCG-1961)

【24h】

The Results of Intensive Chemotherapy Protocols in Children with High Risk Acute Lymphoblastic Leukemia (CCG-106 B, CCG-1882-Augmented BFM and CCG-1961)

机译：高危急性淋巴细胞白血病儿童强化化疗方案的结果（CCG-106 B，CCG-1882-增强型BFM和CCG-1961）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2016年第3期|共1页
作者
Yavuz G.; Unal E.; Tacyildiz N.; Dincaslan H.; Ikinciogullari A.; Dogu F.; Tanyildiz G.; Aksoy B.; Pekpak E.; Asarcikli F.; Babacan E.; Gozdasoglu S.; Cavdar A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. The Results of Intensive Chemotherapy Protocols in Children with High Risk Acute Lymphoblastic Leukemia (CCG-106 B, CCG-1882-Augmented BFM and CCG-1961) [J] . Yavuz G., Unal E., Tacyildiz N., Pediatric blood & cancer . 2016,第Suppla3期

机译：高危急性淋巴细胞白血病儿童强化化疗方案的结果（CCG-106 B，CCG-1882-增强型BFM和CCG-1961）
2. Detection of Minimal Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to the ALL IC-BFM-2002 and ALL IC-BFM 2009 Protocols [J] . Pawinska-Wasikowska K., Bukowska-Strakova K., Surman M., Pediatric blood & cancer . 2017,第Suppla3期

机译：根据全部IC-BFM-2002及所有IC-BFM 2009协议治疗急性淋巴细胞白血病儿童最少的残留疾病的检测
3. Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group [J] . K. Derwich, J. Wachowiak, O. Zając-Spychała, memo - Magazine of European Medical Oncology . 2011,第3期

机译：5.0 g / m 2 相对于3.0 g / m 2 甲氨蝶呤i.v.治疗的标准风险急性淋巴细胞白血病患儿的长期疗效。根据修改后的ALL-BFM 90协议。波兰小儿白血病/淋巴瘤研究组的报告
4. Prediction of Drug Application Optimization Based on RBC Dynamics in Maintenance Chemotherapy of Acute Lymphoblastic Leukemia Maintenance [C] . Probir K. Dhar, Tarun K. Naskar, Durjoy Majumder International Conference on Bioinformatics and Systems Biology . 2018

机译：基于RBC动力学的急性淋巴细胞白血病维持化疗的药物应用优化预测。
5. Acute lymphoblastic leukemia model for the study of immune-mediated tumour rejection and the study of potential therapeutic protocols. [D] . Labbe, Alain. 2005

机译：用于研究免疫介导的肿瘤排斥反应和潜在治疗方案的急性淋巴细胞白血病模型。
6. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol [O] . Gunnar Cario, Peter Rhein, Rita Mitlöhner, 2014

机译：高CD45表面表达决定了根据ALL-BFM 2000协议治疗的前体B细胞和T细胞急性淋巴细胞性白血病患儿的复发风险
7. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol [O] . Cario G, Romey R, Schrauder A, 2010

机译：P2RY8-CRLF2重排的存在与按照ALL-BFM 2000方案治疗的儿童的非高风险前体B细胞急性淋巴细胞白血病的预后不良相关

The Results of Intensive Chemotherapy Protocols in Children with High Risk Acute Lymphoblastic Leukemia (CCG-106 B, CCG-1882-Augmented BFM and CCG-1961)

著录项

相似文献

相关主题

期刊订阅